When enkephalinase is inhibited by sacubitril/valsartan, bradykinin levels in the body increase, leading to vasodilation and increased vascular permeability, which may result in fluid leakage into the alveolar space, causing pulmonary edema. The gene discussed is MME; the disease is pulmonary edema.